CN106062179A - 无血清培养基 - Google Patents

无血清培养基 Download PDF

Info

Publication number
CN106062179A
CN106062179A CN201580008299.8A CN201580008299A CN106062179A CN 106062179 A CN106062179 A CN 106062179A CN 201580008299 A CN201580008299 A CN 201580008299A CN 106062179 A CN106062179 A CN 106062179A
Authority
CN
China
Prior art keywords
medium
serum
mscs
cells
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580008299.8A
Other languages
English (en)
Chinese (zh)
Inventor
F·P·巴里
E·J·穆尼
J·M·墨菲
G·M·肖
S·P·盖纳德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Ireland
Original Assignee
National University of Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Ireland filed Critical National University of Ireland
Publication of CN106062179A publication Critical patent/CN106062179A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201580008299.8A 2014-02-14 2015-02-16 无血清培养基 Pending CN106062179A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14155263.8 2014-02-14
EP14155263 2014-02-14
PCT/EP2015/053223 WO2015121471A1 (en) 2014-02-14 2015-02-16 Serum-free medium

Publications (1)

Publication Number Publication Date
CN106062179A true CN106062179A (zh) 2016-10-26

Family

ID=50101793

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580008299.8A Pending CN106062179A (zh) 2014-02-14 2015-02-16 无血清培养基

Country Status (5)

Country Link
US (1) US10472605B2 (https=)
EP (1) EP3074505B1 (https=)
JP (1) JP2017506511A (https=)
CN (1) CN106062179A (https=)
WO (1) WO2015121471A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112342181A (zh) * 2020-03-26 2021-02-09 中国人民解放军总医院第四医学中心 基于数控激光辐射的非入侵式的细胞成图案方法及系统
CN113621567A (zh) * 2021-07-09 2021-11-09 生物岛实验室 组合物及其应用、干细胞培养基及干细胞的培养方法
CN114286860A (zh) * 2019-08-29 2022-04-05 味之素株式会社 由含有间充质干细胞的生物来源细胞试样制造间充质干细胞的方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102676761B1 (ko) * 2015-12-03 2024-06-18 다카라 바이오 가부시키가이샤 중간엽 줄기세포의 제조방법
CN111334463B (zh) 2016-05-18 2024-02-20 学校法人庆应义塾 类器官培养用细胞培养基、培养方法及类器官
CN112322580B (zh) * 2017-04-28 2022-03-22 北京赛斯达生物技术有限公司 一种间充质干细胞无血清培养基的应用
KR102144593B1 (ko) * 2017-06-07 2020-08-13 주식회사 엑소스템텍 인간줄기세포 유래 엑소좀을 포함하는 세포 배양용 무혈청 배지 조성물
KR102185697B1 (ko) * 2017-10-20 2020-12-03 본 테라퓨틱스 소시에테아노님 중간엽 줄기 세포의 분화 방법
US20210123025A1 (en) * 2018-07-03 2021-04-29 Universidad Del País Vasco - Euskal Herriko Unibertsitatea Cellular aggregates for use in vascularisation therapy
KR102337954B1 (ko) * 2018-08-16 2021-12-10 차의과학대학교 산학협력단 뇌졸중 치료용 조성물 및 이를 스크리닝하는 방법
AU2020310855A1 (en) * 2019-07-08 2022-03-03 Life Technologies Corporation Compositions and methods for enhancing cell culture
JP2021040551A (ja) * 2019-09-11 2021-03-18 富士フイルム株式会社 培地組成物、キット、間葉系幹細胞組成物の製造方法、間葉系幹細胞組成物、間葉系幹細胞、細胞培養上清および細胞外小胞
JP7521738B2 (ja) * 2020-05-18 2024-07-24 キヤノン株式会社 目的細胞の生産方法、目的細胞による生産物の生産方法、および無血清培地

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US20100279412A1 (en) * 2006-01-13 2010-11-04 Japan Science And Technology Agency Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof
WO2013054112A1 (en) * 2011-10-10 2013-04-18 Cell Guidance Systems Limited Culture media for pluripotent stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277623A (ja) * 1985-05-10 1986-12-08 マイルス・ラボラトリ−ス・インコ−ポレ−テツド 哺乳動物の血漿または血清あるいはその分画からコレステロールに富んだ分画を単離しかつ精製する方法
WO1998004681A2 (en) 1996-07-25 1998-02-05 Genzyme Corporation Chondrocyte media formulations and culture procedures
TWI239352B (en) * 1997-07-23 2005-09-11 Takara Bio Inc Gene transfer method with the use of serum-free medium
WO2001016294A2 (en) 1999-08-27 2001-03-08 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
EP1458854B1 (en) 2001-12-21 2010-04-14 Mount Sinai Hospital Cellular compositions and methods of making and using them
US20050265980A1 (en) 2004-05-14 2005-12-01 Becton, Dickinson And Company Cell culture environments for the serum-free expansion of mesenchymal stem cells
CA2792802C (en) 2010-03-10 2017-10-31 Two Cells Co., Ltd. Cell preparation containing mesenchymal stem cells, and method for producing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US20100279412A1 (en) * 2006-01-13 2010-11-04 Japan Science And Technology Agency Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof
WO2013054112A1 (en) * 2011-10-10 2013-04-18 Cell Guidance Systems Limited Culture media for pluripotent stem cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FENXI ZHANG等: "Lectin-like oxidized LDL receptor-1 expresses in mouse bone marrow-derived mesenchymal stem cells and stimulates their proliferation", 《EXPERIMENTAL CELL RESEARCH》 *
郑铁生等: "《临床生物化学检验》", 31 January 2010, 中国医药科技出版社 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114286860A (zh) * 2019-08-29 2022-04-05 味之素株式会社 由含有间充质干细胞的生物来源细胞试样制造间充质干细胞的方法
CN112342181A (zh) * 2020-03-26 2021-02-09 中国人民解放军总医院第四医学中心 基于数控激光辐射的非入侵式的细胞成图案方法及系统
CN112342181B (zh) * 2020-03-26 2021-12-24 中国人民解放军总医院第四医学中心 基于数控激光辐射的非入侵式的细胞成图案方法及系统
CN113621567A (zh) * 2021-07-09 2021-11-09 生物岛实验室 组合物及其应用、干细胞培养基及干细胞的培养方法
CN113621567B (zh) * 2021-07-09 2024-01-30 生物岛实验室 组合物及其应用、干细胞培养基及干细胞的培养方法

Also Published As

Publication number Publication date
EP3074505B1 (en) 2018-06-06
US20170044489A1 (en) 2017-02-16
WO2015121471A1 (en) 2015-08-20
EP3074505A1 (en) 2016-10-05
JP2017506511A (ja) 2017-03-09
US10472605B2 (en) 2019-11-12

Similar Documents

Publication Publication Date Title
CN106062179A (zh) 无血清培养基
CN108251359B (zh) 一种间充质干细胞无血清培养基及培养方法
AU2002322379B2 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
Bidarra et al. Phenotypic and proliferative modulation of human mesenchymal stem cells via crosstalk with endothelial cells
JP6885870B2 (ja) 間葉系幹細胞の細胞培養法
JP6662777B2 (ja) 人工心筋（ｅｈｍ）を産生するための方法
EP2495311B1 (en) Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
US20080152630A1 (en) Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
CN113692282B (zh) 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途
US20080020459A1 (en) Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
Wang et al. The critical role of ECM proteins within the human MSC niche in endothelial differentiation
US20120121546A1 (en) Method of Producing Progenitor Cells from Differentiated Cells
AU2002322379A1 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
KR20130112028A (ko) 무혈청 합성 세포배양 배지
JP7742836B2 (ja) ヒト多能性幹細胞から間葉系幹細胞の製造方法およびこれによって製造された間葉系幹細胞
WO2015042356A1 (en) Chemically defined culture medium for stem cell maintenance and differentiation
WO2007122233A1 (en) Preparation of mesenchymal progenitor cells, particularly osteogenic progenitor cells
US20080113434A1 (en) Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells
US20070042491A1 (en) Amplification of cell populations from embryonic stem cells
EP3872168A1 (en) Chondrocyte differentiation
Szade et al. CD45− CD14+ CD34+ murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture
Čebatariūnienė et al. Microcarrier culture enhances osteogenic potential of human periodontal ligament stromal cells
Ramesh et al. Synergistic effect of inducible factors on the differentiation of human adipose-derived stem cells to vascular cells
Chang et al. Primary adipose-derived stem cells enriched by growth factor treatment improves cell adaptability toward cardiovascular differentiation in a rodent model of acute myocardial infarction
Abdallah et al. Direct differentiation of human embryonic stem cells toward osteoblasts and chondrocytes through an intermediate mesenchyme progenitor lineage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161026